Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Apr;93(4):1422–1429. doi: 10.1172/JCI117119

Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis.

S L Newman 1, L Gootee 1, G Brunner 1, G S Deepe Jr 1
PMCID: PMC294155  PMID: 8163646

Abstract

We investigated the role of intracellular iron on the capacity of Histoplasma capsulatum (Hc) yeasts to multiply within human macrophages (Mphi). Coculture of Hc-infected Mphi with the iron chelator deferoxamine suppressed the growth of yeasts in a concentration-dependent manner. The effect of deferoxamine was reversed by iron-saturated transferrin (holotransferrin) but not by iron-free transferrin (apotransferrin). Chloroquine, which prevents release of iron from transferrin by raising endocytic and lysosomal pH, induced human Mphi to kill Hc. The effect of chloroquine was reversed by iron nitriloacetate, an iron compound that is soluble at neutral to alkaline pH, but not by holotransferrin, which releases iron only in an acidic environment. Chloroquine (40-120 mg/kg) given intraperitoneally for 6 d to Hc-infected C57BL/6 mice significantly reduced the growth of Hc in a dose-dependent manner. At 120 mg/kg there was a 17- and 15-fold reduction (P < 0.01) in CFU in spleens and livers, respectively. The therapeutic effect of chloroquine also correlated with the length of treatment. As little as 2 d of chloroquine therapy (120 mg/kg), when started at day 5 after infection, reduced CFU in the spleen by 50%. Treatment with chloroquine for 10 d after a lethal inoculum of Hc protected six of nine mice; all control mice were dead by day 11 (P = 0.009). This study demonstrates that: (a) iron is of critical importance to the survival and multiplication of Hc yeasts in human Mphi; (b) in vitro, chloroquine induces Mphi killing of Hc yeasts by restricting the availability of intracellular iron; and (c) in vivo, chloroquine significantly reduces the number of organisms in the spleens and livers of Hc-infected mice and can protect mice from a lethal inoculum of Hc yeasts. Thus, chloroquine may be effective in the treatment of active histoplasmosis and also may be useful in preventing relapse of histoplasmosis in patients with acquired immunodeficiency syndromes.

Full text

PDF
1422

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisen P., Leibman A. Lactoferrin and transferrin: a comparative study. Biochim Biophys Acta. 1972 Feb 29;257(2):314–323. doi: 10.1016/0005-2795(72)90283-8. [DOI] [PubMed] [Google Scholar]
  2. Alford C. E., King T. E., Jr, Campbell P. A. Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity. J Exp Med. 1991 Aug 1;174(2):459–466. doi: 10.1084/jem.174.2.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bates G. W., Wernicke J. The kinetics and mechanism of iron(3) exchange between chelates and transferrin. IV. The reaction of transferrin with iron(3) nitrilotriacetate. J Biol Chem. 1971 Jun 10;246(11):3679–3685. [PubMed] [Google Scholar]
  4. Baynes R., Bukofzer G., Bothwell T., Bezwoda W., Macfarlane B. Transferrin receptors and transferrin iron uptake by cultured human blood monocytes. Eur J Cell Biol. 1987 Jun;43(3):372–376. [PubMed] [Google Scholar]
  5. Brummer E., Kurita N., Yoshida S., Nishimura K., Miyaji M. Killing of Histoplasma capsulatum by gamma-interferon-activated human monocyte-derived macrophages: evidence for a superoxide anion-dependent mechanism. J Med Microbiol. 1991 Jul;35(1):29–34. doi: 10.1099/00222615-35-1-29. [DOI] [PubMed] [Google Scholar]
  6. Bullock W. E., Wright S. D. Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J Exp Med. 1987 Jan 1;165(1):195–210. doi: 10.1084/jem.165.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Byrd T. F., Horwitz M. A. Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest. 1991 Jul;88(1):351–357. doi: 10.1172/JCI115301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Byrd T. F., Horwitz M. A. Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J Clin Invest. 1989 May;83(5):1457–1465. doi: 10.1172/JCI114038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Byrd T. F., Horwitz M. A. Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila. J Clin Invest. 1991 Oct;88(4):1103–1112. doi: 10.1172/JCI115409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. CAROLINE L., TASCHDJIAN C. L., KOZINN P. J., SCHADE A. L. REVERSAL OF SERUM FUNGISTASIS BY ADDITION OF IRON. J Invest Dermatol. 1964 Jun;42:415–419. doi: 10.1038/jid.1964.90. [DOI] [PubMed] [Google Scholar]
  11. Crowle A. J., May M. H. Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3. Antimicrob Agents Chemother. 1990 Nov;34(11):2217–2222. doi: 10.1128/aac.34.11.2217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dautry-Varsat A., Ciechanover A., Lodish H. F. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2258–2262. doi: 10.1073/pnas.80.8.2258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Eissenberg L. G., Goldman W. E., Schlesinger P. H. Histoplasma capsulatum modulates the acidification of phagolysosomes. J Exp Med. 1993 Jun 1;177(6):1605–1611. doi: 10.1084/jem.177.6.1605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Finkelstein R. A., Sciortino C. V., McIntosh M. A. Role of iron in microbe-host interactions. Rev Infect Dis. 1983 Sep-Oct;5 (Suppl 4):S759–S777. doi: 10.1093/clinids/5.supplement_4.s759. [DOI] [PubMed] [Google Scholar]
  15. Fleischmann J., Wu-Hsieh B., Howard D. H. The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-gamma. J Infect Dis. 1990 Jan;161(1):143–145. doi: 10.1093/infdis/161.1.143. [DOI] [PubMed] [Google Scholar]
  16. Forsbeck K., Nilsson K. Iron metabolism of established human hematopoietic cell lines in vitro. Exp Cell Res. 1983 Apr 1;144(2):323–332. doi: 10.1016/0014-4827(83)90411-1. [DOI] [PubMed] [Google Scholar]
  17. Gomez F. J., Gomez A. M., Deepe G. S., Jr Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun. 1991 Dec;59(12):4459–4464. doi: 10.1128/iai.59.12.4459-4464.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hendry A. T., Bakerspigel A. Factors affecting serum inhibited growth of Candida albicans and Cryptococcus neoformans. Sabouraudia. 1969 Oct;7(3):219–229. [PubMed] [Google Scholar]
  19. Jacobs A. Low molecular weight intracellular iron transport compounds. Blood. 1977 Sep;50(3):433–439. [PubMed] [Google Scholar]
  20. Krogstad D. J., Schlesinger P. H. Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum. N Engl J Med. 1987 Aug 27;317(9):542–549. doi: 10.1056/NEJM198708273170905. [DOI] [PubMed] [Google Scholar]
  21. Lalonde R. G., Holbein B. E. Role of iron in Trypanosoma cruzi infection of mice. J Clin Invest. 1984 Feb;73(2):470–476. doi: 10.1172/JCI111233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lane T. E., Wu-Hsieh B. A., Howard D. H. Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state. Infect Immun. 1993 Apr;61(4):1468–1473. doi: 10.1128/iai.61.4.1468-1473.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lane T. E., Wu-Hsieh B. A., Howard D. H. Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect Immun. 1991 Jul;59(7):2274–2278. doi: 10.1128/iai.59.7.2274-2278.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Laub R., Schneider Y. J., Octave J. N., Trouet A., Crichton R. R. Cellular pharmacology of deferrioxamine B and derivatives in cultured rat hepatocytes in relation to iron mobilization. Biochem Pharmacol. 1985 Apr 15;34(8):1175–1183. doi: 10.1016/0006-2952(85)90492-7. [DOI] [PubMed] [Google Scholar]
  25. Lestas A. N. The effect of pH upon human transferrin: selective labelling of the two iron-binding sites. Br J Haematol. 1976 Mar;32(3):341–350. doi: 10.1111/j.1365-2141.1976.tb00937.x. [DOI] [PubMed] [Google Scholar]
  26. Litwin C. M., Calderwood S. B. Role of iron in regulation of virulence genes. Clin Microbiol Rev. 1993 Apr;6(2):137–149. doi: 10.1128/cmr.6.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Loo V. G., Lalonde R. G. Role of iron in intracellular growth of Trypanosoma cruzi. Infect Immun. 1984 Sep;45(3):726–730. doi: 10.1128/iai.45.3.726-730.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mackenzie A. H. Pharmacologic actions of 4-aminoquinoline compounds. Am J Med. 1983 Jul 18;75(1A):5–10. doi: 10.1016/0002-9343(83)91264-0. [DOI] [PubMed] [Google Scholar]
  29. Muller D., Edwards M. L., Smith D. W. Changes in iron and transferrin levels and body temperature in experimental airborne legionellosis. J Infect Dis. 1983 Feb;147(2):302–307. doi: 10.1093/infdis/147.2.302. [DOI] [PubMed] [Google Scholar]
  30. Newman S. L., Bucher C., Rhodes J., Bullock W. E. Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest. 1990 Jan;85(1):223–230. doi: 10.1172/JCI114416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Newman S. L., Gootee L., Bucher C., Bullock W. E. Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages. Infect Immun. 1991 Feb;59(2):737–741. doi: 10.1128/iai.59.2.737-741.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Newman S. L., Gootee L. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Infect Immun. 1992 Nov;60(11):4593–4597. doi: 10.1128/iai.60.11.4593-4597.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Newman S. L., Gootee L., Morris R., Bullock W. E. Digestion of Histoplasma capsulatum yeasts by human macrophages. J Immunol. 1992 Jul 15;149(2):574–580. [PubMed] [Google Scholar]
  34. Newman S. L., Musson R. A., Henson P. M. Development of functional complement receptors during in vitro maturation of human monocytes into macrophages. J Immunol. 1980 Nov;125(5):2236–2244. [PubMed] [Google Scholar]
  35. Otto V., Howard D. H. Further studies on the intracellular behavior of Torulopsis glabrata. Infect Immun. 1976 Aug;14(2):433–438. doi: 10.1128/iai.14.2.433-438.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Princiotto J. V., Zapolski E. J. Difference between the two iron-binding sites of transferrin. Nature. 1975 May 1;255(5503):87–88. doi: 10.1038/255087a0. [DOI] [PubMed] [Google Scholar]
  37. Schnur R. A., Newman S. L. The respiratory burst response to Histoplasma capsulatum by human neutrophils. Evidence for intracellular trapping of superoxide anion. J Immunol. 1990 Jun 15;144(12):4765–4772. [PubMed] [Google Scholar]
  38. Sibille J. C., Kondo H., Aisen P. Uptake of ferritin and iron bound to ferritin by rat hepatocytes: modulation by apotransferrin, iron chelators and chloroquine. Biochim Biophys Acta. 1989 Feb 9;1010(2):204–209. doi: 10.1016/0167-4889(89)90162-6. [DOI] [PubMed] [Google Scholar]
  39. Starke P. E., Gilbertson J. D., Farber J. L. Lysosomal origin of the ferric iron required for cell killing by hydrogen peroxide. Biochem Biophys Res Commun. 1985 Dec 17;133(2):371–379. doi: 10.1016/0006-291x(85)90916-7. [DOI] [PubMed] [Google Scholar]
  40. Sutcliffe M. C., Savage A. M., Alford R. H. Transferrin-dependent growth inhibition of yeast-phase Histoplasma capsulatum by human serum and lymph. J Infect Dis. 1980 Aug;142(2):209–219. doi: 10.1093/infdis/142.2.209. [DOI] [PubMed] [Google Scholar]
  41. Swaiman K. F., Machen V. L. Chloroquine reduces neuronal and glial iron uptake. J Neurochem. 1986 Feb;46(2):652–654. doi: 10.1111/j.1471-4159.1986.tb13017.x. [DOI] [PubMed] [Google Scholar]
  42. Van Snick J. L., Masson P. L., Heremans J. F. The involvement of lactoferrin in the hyposideremia of acute inflammation. J Exp Med. 1974 Oct 1;140(4):1068–1084. doi: 10.1084/jem.140.4.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Weinberg E. D. Iron withholding: a defense against infection and neoplasia. Physiol Rev. 1984 Jan;64(1):65–102. doi: 10.1152/physrev.1984.64.1.65. [DOI] [PubMed] [Google Scholar]
  44. Worsham P. L., Goldman W. E. Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores. J Med Vet Mycol. 1988 Jun;26(3):137–143. [PubMed] [Google Scholar]
  45. Wright D. G., Gallin J. I. Secretory responses of human neutrophils: exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo. J Immunol. 1979 Jul;123(1):285–294. [PubMed] [Google Scholar]
  46. Zähringer J., Baliga B. S., Munro H. N. Novel mechanism for translational control in regulation of ferritin synthesis by iron. Proc Natl Acad Sci U S A. 1976 Mar;73(3):857–861. doi: 10.1073/pnas.73.3.857. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES